Final Announcement - page 23

23
29th CINP World
Congress 2014
Topics
The CINP International Scientific Programme Committee
has selected symposia proposals that link the latest pre-
clinical deve­lopments with clinical research on a given
topic. CINP encourages the integration of psychiatric and
neurological perspectives at its congresses. Through the
free and open exchange of ideas, CINP supports a strong
focus on new approaches to the development and assess-
ment of CNS pharmaceuticals by researchers working in
both academia and industry.
For posters the following topics are to be selected:
Theme A
Diseases of the Nervous System. Current preclinical and
clinical perspectives
Sub-topics
l Addictive disorders
l Anxiety disorders
l Bipolar disorder
l Depression
l Eating disorders
l Schizophrenia
l Post-traumatic stress disorder
l Neurodegenerative disorders, including Parkinson’s
disease; Alzheimer’s disease; Huntington’s disease;
fronto-temporal dementia; vascular dementia
l Epilepsy
l Traumatic brain injury and mental health
l Pain
l Sleep disorders
Theme B
Diseases of the Nervous System (Techniques). Current
preclinical and clinical perspectives
Sub-topics
l Neuroimaging
l Neuropathology / post mortem-studies
l Neurophysiology; from ion channels to cortical EEG
Theme C
Innovation in Therapeutic Development and
Assessment of Drugs and Stimulation devices
Sub-topics
l Biomarkers (including pharmacogenomics and brain
imaging) for diagnosis and treatment response
l Clinical Investigator, National Funding Agency,
Public-Private Partnership initiated clinical trials in the
development of novel and effective CNS drugs and
stimulation devices
l Use of traditional medicine to guide novel CNS drug
development
l Psychoneuroimmunology and neuroinflammation
Theme D
Developmental Perspectives on Neuropsycho­-
pharma­cology
Sub-topics
l Autism spectrum disorders
l Attention deficit disorders
l Foetal-alcohol spectrum disorders
l Anxiety disorders and phobias
Theme E
Integrative Approaches to Neuropsychopharmacology
Sub-topics
l Ethics in neuropsychopharmacology
l Gender and mental health
l History of neuropsychopharmacology
l Pharmacoeconomics
l Transcultural psychopharmacology
Theme F
Others
CME Accreditation
The 29th World Congress on Neuropsychopharmacology
2014 is in the process of seeking approval from the Euro-
pean Accreditation Council for Continuing Medical Educa-
tion in Brussels (EACCME) to provide Continuing Medical
Education (CME) credits to physicians for attendance at the
scientific sessions. The EACCME is an institution of the Eu-
ropean Union of Medical Specialists (UEMS).
Through an agreement between the European Union of
Medical Specialists and the American Medical Association,
physicians may convert EACCME credits to an equivalent
number of AMA PRA Category 1 Credits™. Information on
the process to convert EACCME credit to AMA credit can be
found at www.ama-assn.org/go/internationalcme.
topics / CMe Accreditation